U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C9H13NO3
Molecular Weight 183.2044
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NORMETANEPHRINE

SMILES

COC1=CC(=CC=C1O)C(O)CN

InChI

InChIKey=YNYAYWLBAHXHLL-UHFFFAOYSA-N
InChI=1S/C9H13NO3/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,11-12H,5,10H2,1H3

HIDE SMILES / InChI

Molecular Formula C9H13NO3
Molecular Weight 183.2044
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

PubMed

PubMed

TitleDatePubMed
Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population.
2006-11
The role of chromogranin A in the management of patients with phaeochromocytoma.
2006-09
Phaeochromocytoma in pregnancy.
2006-09
Cortisol production rate in posttraumatic stress disorder.
2006-09
Pretreatment and one-shot separating analysis of whole catecholamine metabolites in plasma by using LC/MS.
2006-07
A case of sleep apnea syndrome manifesting severe hypertension with high plasma norepinephrine levels.
2006-06
Absence of exercise-induced leptin suppression associated with insufficient epinephrine reserve in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
2006-03
[Diffuse uptake of brown fat on computed-tomography coupled positron emission tomoscintigraphy (PET-CT) for the exploration of extra-adrenal pheochromocytoma].
2006-03
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass.
2006-03
Low catechol-O-methyltransferase activity in the brain and blood pressure regulation.
2006-02
Paradoxical decrease in blood pressure after relief of cardiac tamponade: the role of sympathetic activity.
2006-02
Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
2006-01-11
Detecting pheochromocytoma: defining the most sensitive test.
2006-01
A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.
2006
Age-related differences in hormonal and nutritional impact on lean anorexia nervosa bone turnover uncoupling.
2006
[Metanephrine (M), normetanephrine (NM) and fractionated metanephrines].
2005-08
Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats.
2005-08
Cyclooxygenase-1-deficient mice have high sleep-to-wake blood pressure ratios and renal vasoconstriction.
2005-06
Improved assay for catechol-O-methyltransferase activity utilizing norepinephrine as an enzymatic substrate and reversed-phase high-performance liquid chromatography with fluorescence detection.
2005-05-13
Rapid assay for catechol-O-methyltransferase activity by high-performance liquid chromatography-fluorescence detection.
2005-05-05
Training of elite cyclists: effects on mood state and selected hormonal responses.
2005-04-02
Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
2005-04
Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.
2005-04
Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas.
2005-03-28
The use of plasma metanephrine to normetanephrine ratio to determine epinephrine poisoning.
2005-03
Expression of human dopamine receptor in potato (Solanum tuberosum) results in altered tuber carbon metabolism.
2005-02-09
Precisely wrong? Urinary fractionated metanephrines and peer-based laboratory proficiency testing.
2005-02
Plasma metanephrines in renal failure.
2005-02
Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour.
2005-01
Pheochromocytoma presenting as heart failure.
2005
Decomposition of protonated noradrenaline and normetanephrine assisted by NH2 migration studied by electrospray tandem mass spectrometry and molecular orbital calculations.
2005
Nonparametric determination of reference intervals for plasma metanephrine and normetanephrine.
2004-12
Assessment of O-methylated catecholamine levels in plasma and urine for diagnosis of autonomic disorders.
2004-11-30
Laparoscopic adrenalectomy for isolated adrenal metastasis.
2004-11-24
Extraneuronal enzymatic degradation of myocardial interstitial norepinephrine in the ischemic region.
2004-10-01
Malignant pheochromocytoma associated with germline mutation of the SDHB gene.
2004-10
Paracetamol-associated interference in an HPLC-ECD assay for urinary free metadrenalines and catecholamines.
2004-07
Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.
2004-07
Predictive value of preoperative transthoracic echocardiography in patients undergoing adrenalectomy for pheochromocytoma.
2004-07
Experience with surgical excision in childhood pheochromocytoma.
2004-06
The economic implications of three biochemical screening algorithms for pheochromocytoma.
2004-06
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrine.
2004-05
Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis.
2004-05
Diagnosis and localization of pheochromocytoma.
2004-05
Hormonal changes during long-term isolation.
2004-05
In vivo assessment of catechol O-methyltransferase activity in rabbit skeletal muscle.
2004-04-30
The catecholamine biosynthesis route in potato is affected by stress.
2004-04-16
Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma.
2004-03
Laparoscopic management of extra-adrenal pheochromocytoma.
2004-01
Alterations of brain tissue in fetal rats exposed to nicotine in utero: possible involvement of nitric oxide and catecholamines.
2002-12-03
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 17:35:41 GMT 2025
Edited
by admin
on Mon Mar 31 17:35:41 GMT 2025
Record UNII
0J45DE6B88
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NORMETANEPHRINE
MI  
Common Name English
(±)-NORMETANEPHRINE
Preferred Name English
3-METHOXYNORADRENALINE
Common Name English
NORMETANEPHRINE [MI]
Common Name English
3-O-METHYLNORADRENALINE
Common Name English
NORMETANEPHRINE, (±)-
Common Name English
3-METHOXYNOREPINEPHRINE
Common Name English
VANILLYL ALCOHOL, .ALPHA.-(AMINOMETHYL)-
Common Name English
3-METHOXY-4-HYDROXYPHENYLETHANOLAMINE
Systematic Name English
DL-3-O-METHYLNOREPINEPHRINE
Common Name English
3-O-METHYLNOREPINEPHRINE
Common Name English
DL-NORMETANEPHRINE
Common Name English
DL-M-O-METHYLNOREPINEPHRINE
Common Name English
3-O-METHYLARTERENOL
Common Name English
4-HYDROXY-3-METHOXY-.ALPHA.-(AMINOMETHYL)BENZYL ALCOHOL
Systematic Name English
.ALPHA.-(AMINOMETHYL)VANILLYL ALCOHOL
Common Name English
.ALPHA.-(AMINOMETHYL)-4-HYDROXY-3-METHOXYBENZENEMETHANOL
Systematic Name English
4-HYDROXY-3-METHOXYPHENETHANOLAMINE
Common Name English
4-(2-AMINO-1-HYDROXYETHYL)-2-METHOXYPHENOL
Systematic Name English
3-METHOXY-4,.BETA.-DIHYDROXYPHENYLETHYLAMINE
Systematic Name English
Classification Tree Code System Code
LOINC 2669-0
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 2670-8
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 25964-8
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 13783-6
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 44924-9
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 2671-6
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 34348-3
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 44342-4
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 25489-6
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 34347-5
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 15083-9
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
LOINC 21422-1
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID70861701
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
PRIMARY
WIKIPEDIA
NORMETANEPHRINE
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
PRIMARY
CAS
97-31-4
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
PRIMARY
PUBCHEM
1237
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
PRIMARY
FDA UNII
0J45DE6B88
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
PRIMARY
MERCK INDEX
m8067
Created by admin on Mon Mar 31 17:35:41 GMT 2025 , Edited by admin on Mon Mar 31 17:35:41 GMT 2025
PRIMARY Merck Index